Kangmei Pharmaceutical Co., Ltd. (600518.SS)
CNY 2.58
(-0.39%)
CNY 2.58
(-0.39%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 536.71 Million CNY | 132.66% |
| 2022 | -1.49 Billion CNY | -109.91% |
| 2021 | 9.86 Billion CNY | 914.34% |
| 2020 | -28.06 Billion CNY | -1426.07% |
| 2019 | -121.46 Million CNY | -103.74% |
| 2018 | 2.99 Billion CNY | -28.69% |
| 2017 | 3.31 Billion CNY | -13.98% |
| 2016 | 5.2 Billion CNY | 24.67% |
| 2015 | 3.54 Billion CNY | 21.48% |
| 2014 | 2.98 Billion CNY | 22.06% |
| 2013 | 2.44 Billion CNY | 27.65% |
| 2012 | 2.18 Billion CNY | 42.77% |
| 2011 | 1.51 Billion CNY | 47.07% |
| 2010 | 923.56 Million CNY | 41.46% |
| 2009 | 649 Million CNY | 58.11% |
| 2008 | 475.71 Million CNY | 58.36% |
| 2007 | 301.24 Million CNY | 47.42% |
| 2006 | 204.75 Million CNY | 34.31% |
| 2005 | 152.44 Million CNY | 5.71% |
| 2004 | 144.2 Million CNY | 34.04% |
| 2003 | 107.58 Million CNY | 36.28% |
| 2002 | 78.94 Million CNY | 35.63% |
| 2001 | 58.2 Million CNY | 14.68% |
| 2000 | 50.75 Million CNY | 28.99% |
| 1999 | 39.35 Million CNY | 131.23% |
| 1998 | 17.01 Million CNY | 72.64% |
| 1997 | 9.85 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -3.26 Million CNY | -103.01% |
| 2024 Q2 | 73.79 Million CNY | 5.46% |
| 2024 Q1 | -27.04 Million CNY | -73.1% |
| 2023 Q3 | -73.39 Million CNY | 3.33% |
| 2023 Q2 | -75.92 Million CNY | -22.89% |
| 2023 FY | - CNY | 132.66% |
| 2023 Q1 | -61.78 Million CNY | 93.8% |
| 2023 Q4 | 353.43 Million CNY | 581.54% |
| 2022 Q1 | -97.76 Million CNY | -100.67% |
| 2022 Q4 | -996.29 Million CNY | -40.87% |
| 2022 Q2 | -60.18 Million CNY | 38.44% |
| 2022 FY | - CNY | -109.91% |
| 2022 Q3 | -707.24 Million CNY | -1075.05% |
| 2021 Q1 | -110.6 Million CNY | 94.12% |
| 2021 FY | - CNY | 914.34% |
| 2021 Q2 | 23.29 Million CNY | 121.06% |
| 2021 Q3 | -94.51 Million CNY | -505.78% |
| 2021 Q4 | 14.67 Billion CNY | 15625.5% |
| 2020 Q1 | 80.46 Million CNY | 102.9% |
| 2020 Q2 | -372.63 Million CNY | -563.12% |
| 2020 Q4 | -1.88 Billion CNY | -509.15% |
| 2020 Q3 | -308.71 Million CNY | 17.15% |
| 2020 FY | - CNY | -1426.07% |
| 2019 Q2 | 553.91 Million CNY | -32.52% |
| 2019 Q4 | -2.77 Billion CNY | -575.96% |
| 2019 Q3 | 582.86 Million CNY | 5.23% |
| 2019 FY | - CNY | -103.74% |
| 2019 Q1 | 820.82 Million CNY | 125.28% |
| 2018 Q3 | 2 Billion CNY | 4.68% |
| 2018 FY | - CNY | -28.69% |
| 2018 Q1 | 2.08 Billion CNY | 745.88% |
| 2018 Q2 | 1.91 Billion CNY | -8.32% |
| 2018 Q4 | -3.24 Billion CNY | -262.3% |
| 2017 Q4 | -322.75 Million CNY | -122.12% |
| 2017 Q1 | 1.64 Billion CNY | 21.14% |
| 2017 Q2 | 1.47 Billion CNY | -10.14% |
| 2017 FY | - CNY | -13.98% |
| 2017 Q3 | 1.45 Billion CNY | -1.01% |
| 2016 Q1 | 1.3 Billion CNY | 16.89% |
| 2016 FY | - CNY | 24.67% |
| 2016 Q4 | 1.35 Billion CNY | 18.34% |
| 2016 Q3 | 1.14 Billion CNY | -4.78% |
| 2016 Q2 | 1.2 Billion CNY | -8.1% |
| 2015 FY | - CNY | 21.48% |
| 2015 Q4 | 1.11 Billion CNY | 22.75% |
| 2015 Q3 | 911.45 Million CNY | -1.94% |
| 2015 Q2 | 929.46 Million CNY | -14.25% |
| 2015 Q1 | 1.08 Billion CNY | 18.78% |
| 2014 Q1 | 896.69 Million CNY | 17.23% |
| 2014 FY | - CNY | 22.06% |
| 2014 Q4 | 912.52 Million CNY | 21.63% |
| 2014 Q3 | 750.26 Million CNY | 2.33% |
| 2014 Q2 | 733.21 Million CNY | -18.23% |
| 2013 FY | - CNY | 27.65% |
| 2013 Q3 | 588.97 Million CNY | -0.06% |
| 2013 Q1 | 749.74 Million CNY | 14.1% |
| 2013 Q2 | 589.34 Million CNY | -21.39% |
| 2013 Q4 | 764.91 Million CNY | 29.87% |
| 2012 Q2 | 473.56 Million CNY | -12.07% |
| 2012 Q1 | 538.56 Million CNY | 3.78% |
| 2012 Q3 | 444.57 Million CNY | -6.12% |
| 2012 Q4 | 657.11 Million CNY | 47.81% |
| 2012 FY | - CNY | 42.77% |
| 2011 FY | - CNY | 47.07% |
| 2011 Q4 | 518.95 Million CNY | 59.6% |
| 2011 Q3 | 325.15 Million CNY | 0.34% |
| 2011 Q2 | 324.04 Million CNY | -5.11% |
| 2011 Q1 | 341.5 Million CNY | -11.29% |
| 2010 Q1 | 208.19 Million CNY | -28.94% |
| 2010 Q3 | 202.38 Million CNY | -6.88% |
| 2010 Q4 | 384.97 Million CNY | 90.22% |
| 2010 FY | - CNY | 41.46% |
| 2010 Q2 | 217.34 Million CNY | 4.39% |
| 2009 Q4 | 293 Million CNY | 130.7% |
| 2009 Q2 | 170.39 Million CNY | 28.11% |
| 2009 FY | - CNY | 58.11% |
| 2009 Q3 | 127 Million CNY | -25.47% |
| 2009 Q1 | 133 Million CNY | -14.81% |
| 2008 Q2 | 136.53 Million CNY | 121.61% |
| 2008 Q1 | 61.61 Million CNY | -28.22% |
| 2008 FY | - CNY | 58.36% |
| 2008 Q4 | 156.13 Million CNY | 63.8% |
| 2008 Q3 | 95.31 Million CNY | -30.19% |
| 2007 Q4 | 85.83 Million CNY | 32.67% |
| 2007 FY | - CNY | 47.42% |
| 2007 Q1 | 39.61 Million CNY | -31.21% |
| 2007 Q3 | 64.69 Million CNY | -10.84% |
| 2007 Q2 | 72.56 Million CNY | 83.18% |
| 2006 Q3 | 54.1 Million CNY | -5.47% |
| 2006 FY | - CNY | 34.31% |
| 2006 Q1 | 38.13 Million CNY | -2.6% |
| 2006 Q2 | 57.23 Million CNY | 50.1% |
| 2006 Q4 | 57.58 Million CNY | 6.43% |
| 2005 Q3 | 38.79 Million CNY | -8.34% |
| 2005 Q1 | 33.07 Million CNY | -19.06% |
| 2005 Q4 | 39.15 Million CNY | 0.92% |
| 2005 FY | - CNY | 5.71% |
| 2005 Q2 | 42.32 Million CNY | 27.98% |
| 2004 Q4 | 40.86 Million CNY | 6.47% |
| 2004 Q3 | 38.37 Million CNY | -8.65% |
| 2004 Q2 | 42.01 Million CNY | 73.43% |
| 2004 Q1 | 24.22 Million CNY | -22.56% |
| 2004 FY | - CNY | 34.04% |
| 2003 Q3 | 22.59 Million CNY | -27.74% |
| 2003 Q1 | 22.48 Million CNY | 36.7% |
| 2003 FY | - CNY | 36.28% |
| 2003 Q2 | 31.26 Million CNY | 39.06% |
| 2003 Q4 | 31.28 Million CNY | 38.46% |
| 2002 Q3 | 16.05 Million CNY | -4.51% |
| 2002 Q2 | 16.81 Million CNY | 29.17% |
| 2002 Q1 | 13.01 Million CNY | 0.0% |
| 2002 FY | - CNY | 35.63% |
| 2002 Q4 | 16.44 Million CNY | 2.42% |
| 2001 FY | - CNY | 14.68% |
| 2000 FY | - CNY | 28.99% |
| 1999 FY | - CNY | 131.23% |
| 1998 FY | - CNY | 72.64% |
| 1997 FY | - CNY | 0.0% |